Literature DB >> 3776390

[Immediate and late results of treating compression forms of lumbar osteochondrosis by the technic of puncture fenestration and decompression of the intervertebral disks].

V V Shchedrenok, A N Sovakov, K I Sebelev.   

Abstract

The authors describe a new method of surgical treatment of compression forms of lumbar osteochondrosis using puncture fenestration and decompression of intervertebral disks. They also present the results of the treatment of 200 patients (the effect was good in 71% of the patients) and a follow-up of 160 patients for as long as 2.5 years after the operation (the result was good in 70% of the patients).

Entities:  

Mesh:

Year:  1986        PMID: 3776390

Source DB:  PubMed          Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova        ISSN: 0044-4588


  54 in total

Review 1.  RAS-targeted therapies: is the undruggable drugged?

Authors:  Amanda R Moore; Scott C Rosenberg; Frank McCormick; Shiva Malek
Journal:  Nat Rev Drug Discov       Date:  2020-06-11       Impact factor: 84.694

Review 2.  The pancreatic cancer genome revisited.

Authors:  Akimasa Hayashi; Jungeui Hong; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-04       Impact factor: 46.802

Review 3.  An unexpected turn of fortune: targeting TRAIL-Rs in KRAS-driven cancer.

Authors:  Silvia von Karstedt; Henning Walczak
Journal:  Cell Death Discov       Date:  2020-03-17

4.  Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody.

Authors:  Shijin Yuan; Yan Xia; Lihong Shen; Liuqing Ye; Lisha Li; Lifen Chen; Xinyou Xie; Haizhou Lou; Jun Zhang
Journal:  Cancer Immunol Immunother       Date:  2020-08-27       Impact factor: 6.968

5.  Germline de novo mutation clusters arise during oocyte aging in genomic regions with high double-strand-break incidence.

Authors:  Jakob M Goldmann; Vladimir B Seplyarskiy; Wendy S W Wong; Thierry Vilboux; Pieter B Neerincx; Dale L Bodian; Benjamin D Solomon; Joris A Veltman; John F Deeken; Christian Gilissen; John E Niederhuber
Journal:  Nat Genet       Date:  2018-03-05       Impact factor: 38.330

6.  Long noncoding RNA NBAT1 suppresses hepatocellular carcinoma progression via competitively associating with IGF2BP1 and decreasing c-Myc expression.

Authors:  Ling Wei; Mengzhi Ling; Song Yang; Yunqian Xie; Changjiang Liu; Wenyi Yi
Journal:  Hum Cell       Date:  2021-01-02       Impact factor: 4.174

Review 7.  The implications of IDH mutations for cancer development and therapy.

Authors:  Christopher J Pirozzi; Hai Yan
Journal:  Nat Rev Clin Oncol       Date:  2021-06-15       Impact factor: 66.675

8.  A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer.

Authors:  Nikhil Wagle; Rachel A Freedman; Sara M Balch; Ines Vaz-Luis; Tianyu Li; Nabihah Tayob; Esha Jain; Karla Helvie; Jorge E Buendia-Buendia; Erin Shannon; Steven J Isakoff; Nadine M Tung; Ian E Krop; Nancy U Lin
Journal:  Breast Cancer Res Treat       Date:  2021-07-24       Impact factor: 4.872

9.  Sarcoma Tumor Microenvironment.

Authors:  Panagiotis Tsagozis; Jordi Gonzalez-Molina; Anna-Maria Georgoudaki; Kaisa Lehti; Joseph Carlson; Andreas Lundqvist; Felix Haglund; Monika Ehnman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma.

Authors:  Zhi-Qiang Hu; Hao-Yang Xin; Chu-Bin Luo; Jia Li; Zheng-Jun Zhou; Ji-Xue Zou; Shao-Lai Zhou
Journal:  Cancer Immunol Immunother       Date:  2020-08-06       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.